Allan May - Profile and Investment Details

Investor Profile

Allan May is a Venture Capital, Founder, Angel Group, Private Equity Firm, Investor based in Redwood City, California, United States with a diverse investment portfolio that includes companies such as Trak, Fluxion Biosciences, Satoris, Ask.Vet, Physcient, Carmenta Bioscience, Virion Therapeutics, Zogenix, Nanotech Biomachines, Altheos, Allylix, Retrotope, VALFIX Medical, Chameleon Biosciences, Anubis Bio, First Light Diagnostics, Velomedix, Avisi Technologies, Pegasus Biologics, OncoHealthnVision Medical, Zephyrus Biosciences, VasoNova, Breathe Technologies, Verdezyne, Niveus Medical, FundamentalVR, Gemmus Pharma, Mission Bio, Thrive Bioscience, Vaxart, . Over time, Allan May has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Allan May is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Women Founded, Investment Management, Healthcare Innovation, Life Science, Engineering, Portfolio Management, Information Technology (IT), Due Diligence Services, Cloud Computing, Venture Fundraising, Bioinformatics, Software, Biotechnology, Medical Devices, Genomics, Nutrition, Clinical Trials, Reviews and Recommendations, Pets, Digital Health, Nanotechnology, Professional Networking, Medical, SaaS, Information Technology, B2B, Therapeutics, Health Tech, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Allan May, as their portfolio suggests a familiarity and interest in this area.

Understanding Allan May’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.